Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lotus Pharm Proxy Solicitation & Information Statement 2019

Jul 1, 2019

51923_rns_2019-07-01_0e74a919-537f-4e89-a845-abc13e90d3ee.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

==> picture [160 x 37] intentionally omitted <==

Meeting Notice

For

2019 First Extraordinary General Meeting

(Summary Translation)

The 2019 First Extraordinary General Meeting (the “Meeting”) of Lotus Pharmaceutical Co., Ltd. (the “Company”) will be convened at 9:00 a.m., Wednesday, February 20[th] , 2019 at No.21, Nangang 3[rd] Rd., Nantou City, Nantou County 540, Taiwan (R.O.C.), and

The Agenda for the Meeting is as follows:

I. Discussion Items:

(1) Proposal for private placement

II. Special Motions

III. Adjournment

Board of Directors

Lotus Pharmaceutical Co., Ltd.